We showed that policosanol, which is generally thought to reduce LDL and increase HDL cholesterol levels in the blood, had no significant effect on the expression of lipid metabolism-related genes (lips-17 and lipl-4) in the transgenic AD model. The gene discussed is LIPN; the disease is Alzheimer disease.